CN Patent

CN109248323B — 酰化的glp-1衍生物

Assigned to Hangzhou Xianweida Biotechnology Co ltd · Expires 2023-09-08 · 3y expired

What this patent protects

本发明提供了GLP‑1(7‑37)多肽衍生物的脂肪酸修饰的缀合物。另外，本发明还提供了该肽缀合物的制备方法、含该肽缀合物的药物以及在制备药物中的用途和中间体等。

USPTO Abstract

本发明提供了GLP‑1(7‑37)多肽衍生物的脂肪酸修饰的缀合物。另外，本发明还提供了该肽缀合物的制备方法、含该肽缀合物的药物以及在制备药物中的用途和中间体等。

Drugs covered by this patent

Patent Metadata

Patent number
CN109248323B
Jurisdiction
CN
Classification
—
Expires
2023-09-08
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Xianweida Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.